The Potential Benefit of Hypoxic Cytotoxins in Radio-Oncology-Reference-Cited by-同舟云学术

The Potential Benefit of Hypoxic Cytotoxins in Radio-Oncology

Published:2000 Issue: Volume: Page:219-229
ISSN:0942-5373
Container-title:Blood Perfusion and Microenvironment of Human Tumors
language:
Short-container-title:

Author:

Brown J. M.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-642-58813-6_18.pdf

Reference60 articles.

1. Adams GE, Cooke MS (1969) Electron-affinic sensitization. I. A structural basis for chemical radiosensitizers in bacteria. Int J Radiat Biol 15:457–471

2. Adams GE, Ahmed I, Sheldon PW, Stratford IJ (1984) RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio-and chemosensitizer in vitro and in vivo. Int J Radiat Oncol Biol Phys 10:1653–1656

3. Adams GE, Stratford IJ, Edwards HS, Bremner JC, Cole S (1992) Bioreductive drugs as post-irradiation sensitizers: comparison of dual function agents with SR 4233 and the mitomycin C analogue E09. Int J Radiat Oncol Biol Phys 22:717–720

4. Ahmed I, Jenkins TC, Walling JM, Stratford IJ, Sheldon PW, Adams GE, Fielden EM (1986) Analogues of RSU-1069: radiosensitization and toxicity in vitro and in vivo. Int J Radiat Oncol Biol Phys 12:1079–1081

5. Baker MA, Zeman EM, Hirst VK, Brown JM (1988) Metabolism of SR 4233 by Chinese hamster ovary cells: basis of selective hypoxic cytotoxicity. Cancer Res 48:5947–5952

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer;British Journal of Cancer;2000